The overall goal of this project is (1) to evolve in situ RT-PCR to the point where it can become routine for basic, epidemiological and cancer research and (2) increase the throughput of in situ RT-PCR to conduct whole genome profiling of human tumor viruses (and eventually multi-gene arrays of human oncogenes). To achieve uniformity of performance, we rely on our previously validated real-time primer set for Kaposi's sarcoma-associated herpesvirus (HHV-8/KSHV) (Dittmer, Cancer Research 63:2010-15 (2003)), which exhibits extremely uniform amplification efficiencies for each primer pair. We will test the appropriateness of this 82 primer set for in situ real-time RT-PCR of tumor sections; we will compare--on the same sample--whole tumor transcription profiling to in situ analysis for all mRNAs in the viral genome; and we will validate both procedures relative to viral protein expression. Even though this R03 application uses KS and KSHV primarily as a test case to validate this technology, looking at KS and KSHV transcription this study in itself will yield valuable information about the biology of this disease, because tumor heterogeneity is one of the defining characteristics of KS. In KS lesions tumor progression depends on and responds to viral gene expression. This study will provide a road map for a better understanding of KS biology and clinical classification of KS tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA110136-02
Application #
6938460
Study Section
Special Emphasis Panel (ZCA1-SRRB-Q (M1))
Program Officer
Wagner, Paul D
Project Start
2004-08-17
Project End
2007-07-31
Budget Start
2005-08-12
Budget End
2007-07-31
Support Year
2
Fiscal Year
2005
Total Cost
$73,000
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Mutlu, Agata D'Agostino; Cavallin, Lucas E; Vincent, Loic et al. (2007) In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 11:245-58
Staudt, M R; Dittmer, D P (2007) The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Curr Top Microbiol Immunol 312:71-100
An, Feng-Qi; Folarin, Hope Merlene; Compitello, Nicole et al. (2006) Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo. J Virol 80:4833-46
Wang, Ling; Dittmer, Dirk P; Tomlinson, Christine C et al. (2006) Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res 66:3658-66
Hilscher, Chelsey; Vahrson, Wolfgang; Dittmer, Dirk P (2005) Faster quantitative real-time PCR protocols may lose sensitivity and show increased variability. Nucleic Acids Res 33:e182